Tag: best econometrics and finance award

Kamal Tasiu | Econometrics and Finance | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Kamal Tasiu — Istanbul University, Turkey

Kamal Tasiu
Affiliation Istanbul University
Country Turkey
Scopus ID 57217050164
Documents 5
Citations 59
h-index 4
Subject Area Econometrics and Finance
Event World Science Awards
ORCID 0000-0001-6268-8339

Kamal Tasiu is a researcher affiliated with Istanbul University, Turkey, whose supplied academic profile is associated with the field of Econometrics and Finance. The researcher is identified by Scopus Author ID 57217050164 and ORCID iD 0000-0001-6268-8339. [1] [2] This profile presents the available researcher-identification information and places the academic record within the broader context of quantitative economic and financial research.

Abstract

This academic recognition profile presents the supplied research information for Kamal Tasiu of Istanbul University, Turkey. The researcher’s identified subject area is Econometrics and Finance, a field encompassing quantitative economic analysis, financial modelling, statistical inference, econometric methods, and related applications. The supplied researcher identifiers include Scopus Author ID 57217050164 and ORCID iD 0000-0001-6268-8339. [1] [2] The available information is presented without attributing specific research findings that were not included in the supplied data.

Keywords

Kamal Tasiu; Innovative Research Award; Econometrics and Finance; Istanbul University; econometrics; financial economics; quantitative finance; economic modelling; statistical analysis; financial modelling; research methodology; academic research; scholarly communication; Turkey.

Introduction

Econometrics and Finance combine economic theory, statistical methods, mathematical modelling, and empirical analysis to investigate economic and financial phenomena. Econometric research can involve the development and application of statistical models for estimating relationships among economic variables, testing hypotheses, forecasting outcomes, and evaluating economic processes. Financial research may similarly address markets, risk, investment, financial institutions, asset pricing, and quantitative decision-making.

Innovative research in these fields can involve new methodological approaches, improved models, novel datasets, empirical techniques, or applications that provide additional evidence about economic and financial systems. Assessment of research innovation should consider the research question, methodological rigor, originality, reproducibility, relevance, and contribution to the existing scholarly literature rather than relying on a single quantitative indicator.

Research Profile

The supplied profile identifies Kamal Tasiu as being affiliated with Istanbul University in Turkey and associates the researcher with Econometrics and Finance. The Scopus Author ID provided is 57217050164, while the ORCID identifier is 0000-0001-6268-8339. [1] [2] These persistent identifiers can support the distinction of an individual researcher from other authors with similar names.

Research Contributions

The supplied subject classification places Kamal Tasiu’s research profile within Econometrics and Finance. Research in this area can contribute to the understanding of economic relationships and financial systems through quantitative modelling, empirical analysis, statistical estimation, forecasting, and evaluation of financial or economic data.

The supplied information does not identify individual publications, specific research findings, datasets, models, patents, software, or methodological innovations. Accordingly, no specific discovery or technical contribution is attributed to the researcher beyond the supplied institutional and subject-area information. Detailed assessment of research contributions would require examination of the underlying scholarly outputs.

  • Research profile associated with Econometrics and Finance.
  • Academic affiliation with Istanbul University, Turkey.

Publications

The supplied information identifies a Scopus author profile for Kamal Tasiu but does not provide individual publication titles, publication dates, journal names, co-authors, citation counts, or DOI identifiers. [1] Specific publications are therefore not listed or attributed in this article without verification.

For a publication-level evaluation, each scholarly output can be examined for methodological rigor, originality, research question, data quality, analytical approach, publication venue, citation context, and DOI or other persistent identifier. Such an assessment would provide more detailed evidence regarding the nature and significance of the research record.

Research Impact

The available input does not include citation totals, document counts, or h-index values for the researcher. Consequently, no numerical bibliometric impact measure is assigned in this profile. The absence of supplied metrics should not be interpreted as evidence for or against research impact.

In Econometrics and Finance, research impact can be examined through several dimensions, including scholarly citations, methodological adoption, use of datasets or models, influence on subsequent research, relevance to economic or financial decision-making, policy applications, and contributions to professional or academic practice. Bibliometric indicators should be interpreted in conjunction with qualitative evidence and disciplinary context. [3]

Award Suitability

The supplied profile provides identifiable academic and researcher information relevant to an Innovative Research Award profile in Econometrics and Finance. Kamal Tasiu is associated with Istanbul University and is identified through both Scopus Author ID 57217050164 and ORCID iD 0000-0001-6268-8339. [1] [2]

A complete award assessment should consider verified scholarly outputs, originality of research questions, methodological contribution, quality of evidence, disciplinary relevance, authorship contribution, research dissemination, and documented influence. Because publication-level evidence and bibliometric totals were not supplied, these aspects should be verified before drawing conclusions about the extent of research innovation.

  • Identified academic affiliation with Istanbul University.
  • Research subject area identified as Econometrics and Finance.
  • Publication-level evidence remains necessary for detailed evaluation of innovative research contributions.

Conclusion

Kamal Tasiu’s supplied academic profile identifies an affiliation with Istanbul University in Turkey and a research subject area of Econometrics and Finance. The researcher is associated with Scopus Author ID 57217050164 and ORCID iD 0000-0001-6268-8339. [1] [2]

The available information establishes the researcher’s identity and broad academic field but does not provide sufficient publication-level or bibliometric information to characterize specific innovations or quantify research impact. A comprehensive Innovative Research Award assessment should therefore incorporate verified scholarly outputs, methodological originality, research quality, disciplinary contribution, and documented influence.

References

  1. Elsevier. (n.d.). Scopus author details: Kamal Tasiu, Author ID 57217050164. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57217050164
  2. ORCID. (n.d.). ORCID record: Kamal Tasiu, ORCID iD 0000-0001-6268-8339.
    https://orcid.org/0000-0001-6268-8339
  3. Hicks, D., Wouters, P., Waltman, L., de Rijcke, S., & Rafols, I. (2015). Bibliometrics: The Leiden Manifesto for research metrics. Nature, 520, 429–431.
    DOI: https://doi.org/10.1038/520429a
  4. World Science Awards. (n.d.). World Science Awards.
    https://shen.sciencefather.com/

Avanidhar Subrahmanyam | Econometrics and Finance | Best Researcher Award

Published on by World Science Awards

Prof. Avanidhar Subrahmanyam | Econometrics and Finance | Best Researcher Award

UCLA | United States 

Prof. Avanidhar Subrahmanyam is a globally recognized scholar in finance whose work has significantly shaped contemporary understanding of market microstructure, asset pricing, liquidity dynamics, and behavioral influences in financial decision-making. With a prolific academic record of 122 research documents, more than 15,960 citations, and an h-index of 49, he ranks among the most influential voices in modern financial economics. His research has appeared in premier journals and is frequently referenced in policy discussions, regulatory modeling, and advanced financial analytics, underscoring the practical relevance and theoretical depth of his contributions. Prof. Subrahmanyam is particularly renowned for pioneering insights into how investor psychology, information asymmetries, and market frictions influence asset prices and trading behavior—work that has advanced both academic discourse and real-world market design. His expertise extends across empirical finance, econometric modeling, and interdisciplinary research intersecting economics, psychology, and data science. Throughout his career, he has actively collaborated with leading international researchers, contributing to multi-institutional and cross-disciplinary projects that enhance global understanding of financial markets. These collaborations have resulted in influential frameworks used by practitioners, central banks, investment institutions, and risk-management bodies. His scholarship has played a critical role in informing studies related to liquidity crises, high-frequency trading, behavioral anomalies, and investor welfare, providing valuable guidance to regulators and industry leaders seeking to design stable and transparent markets. Prof. Subrahmanyam’s work also carries strong societal impact, offering analytical foundations for improving market fairness, mitigating systemic risks, and strengthening the financial resilience of economies.

Profiles: Scopus | Google Scholar

Featuered Publications

Daniel, K., Hirshleifer, D., & Subrahmanyam, A. (1998). Investor psychology and security market under‐ and overreactions. The Journal of Finance, 53(6), 1839–1885.

Brennan, M. J., & Subrahmanyam, A. (1996). Market microstructure and asset pricing: On the compensation for illiquidity in stock returns. Journal of Financial Economics, 41(3), 441–464.

Chordia, T., Roll, R., & Subrahmanyam, A. (2000). Commonality in liquidity. Journal of Financial Economics, 56(1), 3–28.

Chordia, T., Roll, R., & Subrahmanyam, A. (2001). Market liquidity and trading activity. The Journal of Finance, 56(2), 501–530.

Brennan, M. J., Chordia, T., & Subrahmanyam, A. (1998). Alternative factor specifications, security characteristics, and the cross-section of expected stock returns. Journal of Financial Economics, 49(3), 345–373.

Rena Conti | Econometrics and Finance | Best Researcher Award

Published on by World Science Awards

Prof. Rena Conti | Econometrics and Finance | Best Researcher Award

Questrom School of Business, Boston University | United States

Professor Rena M. Conti is a distinguished scholar in health economics and public policy, renowned for her influential contributions to the economics of healthcare markets, pharmaceutical innovation, and drug pricing regulation. With 156 scholarly publications, over 4,890 citations, and an h-index of 31, she has established herself as a global authority in the intersection of healthcare policy, economic analysis, and market dynamics. Her research focuses on understanding the mechanisms driving biopharmaceutical pricing, access to essential medicines, and the sustainability of healthcare systems. Professor Conti’s work has been featured in leading international journals, including JAMA, Health Affairs, and Nature Biotechnology, where her empirical analyses have informed both academic discourse and practical policymaking. Her collaborations extend across academia, government, and industry, where she has worked with public health agencies, pharmaceutical firms, and think tanks to design evidence-based policies that promote innovation while ensuring patient affordability. A key aspect of her impact lies in her ability to bridge the gap between economic modeling and real-world policy implementation, offering pragmatic solutions for optimizing market efficiency and health outcomes. She has also been actively involved in mentoring young researchers and contributing to interdisciplinary initiatives that explore the ethical, economic, and regulatory dimensions of healthcare innovation. Her leadership in shaping policy frameworks related to biosimilars, value-based pricing, and healthcare equity has positioned her as a leading voice in advancing sustainable global health systems. Beyond academia, her work has contributed to public debates on balancing innovation incentives with affordability, influencing policymakers and industry leaders worldwide. Through her rigorous scholarship, collaborative outlook, and commitment to public health, Professor Conti continues to play a pivotal role in transforming the global conversation on healthcare economics, ensuring that economic research serves both scientific advancement and social equity.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., & Lindau, S. T. (2008). Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA, 300(24), 2867–2878.

Epstein, A. M., Ayanian, J. Z., Keogh, J. H., Noonan, S. J., Armistead, N., Cleary, P. D., … (et al.) (2000). Racial disparities in access to renal transplantation—clinically appropriate or due to underuse or overuse? New England Journal of Medicine, 343(21), 1537–1544.

Howard, D. H., Bach, P. B., Berndt, E. R., & Conti, R. M. (2015). Pricing in the market for anticancer drugs. Journal of Economic Perspectives, 29(1), 139–162.

Dorsey, E. R., Rabbani, A., Gallagher, S. A., Conti, R. M., & Alexander, G. C. (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170(1), 96–103.

Dusetzina, S. B., Higashi, A. S., Dorsey, E. R., Conti, R., Huskamp, H. A., Zhu, S., … (et al.) (2012). Impact of FDA drug risk communications on health care utilization and health behaviors: A systematic review. Medical Care, 50(6), 466–478.